Clinical Trial Update: Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports safety and pharmacokinetics data for clindamycin in pediatric subjects with BMI at or above the 85th percentile. The results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Obesity

Drugs mentioned

• Clindamycin

Snippet

Sponsor: Phillip Brian Smith | Conditions: Bacterial Infections, Obesity | Phase 1 | Status: COMPLETED | Results posted: 2016-10-19